Fig. 5From: Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor TherapySchematic illustration of activated NK cells (NK-92 cells) and NK-92 cell membrane-derived fusogenic liposomes (NKsomes) for targeted tumor therapy [63]. Copyright 2018 Elsevier LtdBack to article page